TW200633697A - Therapeutic agent for chronic obstructive pulmonary disease - Google Patents

Therapeutic agent for chronic obstructive pulmonary disease

Info

Publication number
TW200633697A
TW200633697A TW094146024A TW94146024A TW200633697A TW 200633697 A TW200633697 A TW 200633697A TW 094146024 A TW094146024 A TW 094146024A TW 94146024 A TW94146024 A TW 94146024A TW 200633697 A TW200633697 A TW 200633697A
Authority
TW
Taiwan
Prior art keywords
group
chronic obstructive
therapeutic agent
pulmonary disease
obstructive pulmonary
Prior art date
Application number
TW094146024A
Other languages
English (en)
Inventor
Akinori Arimura
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Publication of TW200633697A publication Critical patent/TW200633697A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW094146024A 2004-12-24 2005-12-23 Therapeutic agent for chronic obstructive pulmonary disease TW200633697A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2004372987 2004-12-24

Publications (1)

Publication Number Publication Date
TW200633697A true TW200633697A (en) 2006-10-01

Family

ID=36601761

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094146024A TW200633697A (en) 2004-12-24 2005-12-23 Therapeutic agent for chronic obstructive pulmonary disease

Country Status (3)

Country Link
JP (1) JPWO2006068162A1 (zh)
TW (1) TW200633697A (zh)
WO (1) WO2006068162A1 (zh)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2225250C (en) * 1995-06-21 2005-03-22 Shionogi & Co., Ltd. Bicyclic amino derivatives and pgd2 antagonist containing the same
CZ297324B6 (cs) * 1996-12-13 2006-11-15 Shionogi & Co., Ltd. Benzothiofenkarboxamidové deriváty a antagonisty PGD2, které je obsahují
JP3857525B2 (ja) * 1998-06-03 2006-12-13 塩野義製薬株式会社 Ｐｇｄ２拮抗剤を含有する痒みの治療剤
CA2402174A1 (en) * 2000-03-09 2001-09-13 Ono Pharmaceutical Co., Ltd. Indole derivatives, process for preparation of the same and use thereof
JPWO2003022814A1 (ja) * 2001-09-07 2004-12-24 小野薬品工業株式会社 インドール誘導体化合物
JP4292402B2 (ja) * 2001-09-07 2009-07-08 小野薬品工業株式会社 インドール誘導体化合物、それらの製造方法およびそれらを有効成分として含有する薬剤
AR038136A1 (es) * 2002-01-24 2004-12-29 Merck Frosst Canada Inc Cicloalcanindoles con sustitucion con fluor composiciones que contienen estos compuestos y metodos de tratamiento
SE0200411D0 (sv) * 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
SE0200356D0 (sv) * 2002-02-05 2002-02-05 Astrazeneca Ab Novel use
WO2003078409A1 (fr) * 2002-03-19 2003-09-25 Ono Pharmaceutical Co., Ltd. Composes d'acide carboxylique et medicaments renfermant les composes comme principe actif

Also Published As

Publication number Publication date
JPWO2006068162A1 (ja) 2008-06-12
WO2006068162A1 (ja) 2006-06-29

Similar Documents

Publication Publication Date Title
ATE440603T1 (de) 8-hydroxychinolinderivate
GB0324654D0 (en) Medicinal compounds
MY148480A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
NO20065061L (no) Benzoksazin for behandling av sykdommer i luftveiene
NO20076319L (no) Farmasoytiske sammensetninger av et neuroaktivt steroid og anvendelse derav
HK1119699A1 (en) Pyridopyrimidinone inhibitors of pi3kalpha
WO2005063745A8 (en) Novel spiroindoline or spiroisoquinoline compounds, methods of use and compositions thereof
PT1940839E (pt) Inibidores de piridopirimidinona pi3k alfa
CY1107853T1 (el) Χρησεις αντισπασμωδικων αμινοξεων για τη θεραπευτικη αγωγη διπολικων διαταραχων
PL369108A1 (en) 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
HRP20090281T1 (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
MXPA06009475A (es) Derivados de quinazolina y usos terapeuticos de los mismos.
JP2011527334A5 (zh)
MX2013005826A (es) Benzoxazepinas como inhibidores de fosfatidilinositol 3-cinasa/objetivo de rapamicina en mamiferos (p13k/mtor) y metodos de uso y fabricacion.
CY1110373T1 (el) Συνεργιστικος συνδυασμος που περιλαμβανει ροφλουμιλαστη και εναν αντιχολινεργικο παραγοντα που επιλεγεται απο αλατα τιοτροπιου για την θεραπεια αναπνευστικων ασθενειων
DE60206911D1 (de) Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren
UA95766C2 (ru) Производные терфенила для лечения болезни альцгеймера
MX346186B (es) Inhibidores de proteina cinasas.
WO2009025785A3 (en) Cb2 receptor ligands for the treatment of pain
NO20082112L (no) 3-Amino-2-arylpropylazaindoler og deres anvendelse
MXPA05005790A (es) Aminoalcoxiindoles como ligandos del receptor 5-ht6 para el tratamiento de enfermedades del sistema nervioso central.
MXPA03011702A (es) Composicion que comprende un inhibidor de fosodiesterasa 4 y un antagonista de receptor h1 y el uso de los mismos para la elaboracion de un medicamento para el tratamiento de enfermedades respiratorias.
TW200700390A (en) Metabolites for nk-1 antagonists for emesis
TW200635592A (en) Pyridyl-substituted spiro-hydantoin compounds and use thereof
DE60127535D1 (de) Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation